NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 6 filers reported holding NLS PHARMACEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 21,700 | $31,000 | 0.00% |
| UBS Group AG | 10,582 | $15,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 14,362 | $20,000 | 0.00% |
| Citadel Advisors | 21,632 | $31,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,665 | $5,000 | 0.00% |